ZBNA
RYTM icon

Zions Bancorporation, National Association’s Rhythm Pharmaceuticals RYTM Stock Holding History

Zions Bancorporation, National Association’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.22K Buy
+56
New +$5.06K ﹤0.01% 1021

Other funds holding RYTM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Zions Bancorporation, National Association's RYTM Position: Q2 2026 in Review

Zions Bancorporation, National Association opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 56 shares worth $6.22K. The stake represents ﹤0.01% of the portfolio and ranks #1021 among its holdings.

52 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Zions Bancorporation, National Association held 56 shares of Rhythm Pharmaceuticals worth $6.22K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Zions Bancorporation, National Association position in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1021 holding.
  • 52 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.